Loading...

Tekla Life Sciences Investors

HQLNYSE
Financial ServicesAsset Management
$12.79
$0.26(2.08%)

Tekla Life Sciences Investors (HQL) AI-Powered Stock Analysis

See how Tekla Life Sciences Investors scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.

Model Information

The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Tekla Life Sciences Investors (HQL) Stock Overall Grade

Tekla Life Sciences Investors’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.

A

Good

Grade Breakdown by Metric

See how each financial and market factor contributes to Tekla Life Sciences Investors's overall stock rating.

Forecast

B

Score

63/100

Financial Growth

A+

Score

100/100

Fundamental Growth

B+

Score

71/100

Key Ratios

A

Score

82/100

Sector Comparison

A+

Score

100/100

Industry Comparison

A+

Score

90/100

S&P 500 Benchmark

A

Score

85/100

Analyst Consensus

C+

Score

50/100

Component Analysis Explained

Understand the key factors behind each Tekla Life Sciences Investors stock grade, including financials, comparisons, and forecasts.

Frequently Asked Questions